Teva, Actavis, others file replies for dismissing US claims over generic drugs
MLex Summary: Teva Pharmaceuticals, Actavis, Heritage Pharmaceuticals and other generic drug companies filed replies in support of their motions to dismiss US antitrust claims filed by self-funded direct-action plaintiffs. They said...To view the full article, register now.
Already a subscriber? Click here to view full article